MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chern, Y.
Right arrow Articles by Tsai, M. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chern, Y.
Right arrow Articles by Tsai, M. H.

Regulation of adenylyl cyclase type VI activity during desensitization of the A2a adenosine receptor-mediated cyclic AMP response: role for protein phosphatase 2A

Y Chern, JY Chiou, HL Lai and MH Tsai

Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan, Republic of China.

We reported earlier that inhibition of adenylyl cyclase activity is a mechanism involved in desensitization of the A2a adenosine receptor- mediated cAMP response (A2a desensitization) in rat pheochromocytoma PC- 12 cells. Here, we investigated the molecular mechanism that modulates adenylyl cyclase activity during A2a desensitization. Reversible inhibition of forskolin-evoked adenylyl cyclase activity in desensitized cells occurred after incubation with an A2a-selective adenosine agonist (CGS21680). However, when okadaic acid (a relatively protein phosphatase 2A-specific phosphatase inhibitor) was added after agonist removal, adenylyl cyclase activity did not recover. Okadaic acid caused significant dose-dependent inhibition of adenylyl cyclase activity in intact PC-12 cells. Prolonged exposure of okadaic acid- treated PC-12 cells to adenosine agonists did not evoke further inhibition, suggesting that the inhibition of adenylyl cyclase activity during A2a desensitization may operate through a pathway that overlaps with the increased phosphorylation caused by okadaic acid. Inclusion of calcium in the adenylyl cyclase assay significantly inhibited cyclase activity. indicating that PC-12 cells contain Ca(2+)-inhibitable type VI adenylyl cyclase (AC6). This was confirmed by polymerase chain reaction-based detection of AC6 cDNA. Furthermore, incubation of PC-12 cell membrane fractions with purified protein phosphatase 2A or coexpression of protein phosphatase 2A with AC6 in COS-1 cells significantly increased AC6 activity. To reduce the possible influence of Gs alpha protein, we substituted guanosine-5'-O-(2-thio)diphosphate and MnCl2 for GTP and MgCl2, respectively, in some cyclase assays and found that the suppression of AC6 during A2a desensitization and okadaic acid treatment remained largely unchanged. Taken together, these data suggest that phosphorylation of AC6 might account for the inhibition of adenylyl cyclase activity during A2a desensitization in PC-12 cells.

Volume 48, Issue 1, pp. 1-8, 07/01/1995
Copyright © 1995 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
J. Che, E. S. L. Chan, and B. N. Cronstein
Adenosine A2A Receptor Occupancy Stimulates Collagen Expression by Hepatic Stellate Cells via Pathways Involving Protein Kinase A, Src, and Extracellular Signal-Regulated Kinases 1/2 Signaling Cascade or p38 Mitogen-Activated Protein Kinase Signaling Pathway
Mol. Pharmacol., December 1, 2007; 72(6): 1626 - 1636.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-l. Chou, C.-L. Huang, H.-L. Lai, A. C. Hung, C.-L. Chien, Y.-Y. Kao, and Y. Chern
Regulation of Type VI Adenylyl Cyclase by Snapin, a SNAP25-binding Protein
J. Biol. Chem., October 29, 2004; 279(44): 46271 - 46279.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. Linden
Autoregulation of Cyclic AMP in Vascular Smooth Muscle: A Role for Adenosine Receptors
Mol. Pharmacol., November 1, 2002; 62(5): 969 - 970.
[Full Text] [PDF]


Home page
Br J AnaesthHome page
K. W. Miller
The nature of sites of general anaesthetic action
Br. J. Anaesth., July 1, 2002; 89(1): 17 - 31.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
R. K. Sunahara and R. Taussig
Isoforms of Mammalian Adenylyl Cyclase: Multiplicities of Signaling
Mol. Interv., June 1, 2002; 2(3): 168 - 184.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T.-H. Lin, H.-L. Lai, Y.-Y. Kao, C.-N. Sun, M.-J. Hwang, and Y. Chern
Protein Kinase C Inhibits Type VI Adenylyl Cyclase by Phosphorylating the Regulatory N Domain and Two Catalytic C1 and C2 Domains
J. Biol. Chem., May 3, 2002; 277(18): 15721 - 15728.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
B. B. Fredholm, A. P. IJzerman, K. A. Jacobson, K.-N. Klotz, and J. Linden
International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
Pharmacol. Rev., December 1, 2001; 53(4): 527 - 552.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
N. R. Zahniser, J. K. Simosky, R. D. Mayfield, C. A. Negri, T. Hanania, G. A. Larson, M. A. Kelly, D. K. Grandy, M. Rubinstein, M. J. Low, et al.
Functional Uncoupling of Adenosine A2A Receptors and Reduced Response to Caffeine in Mice Lacking Dopamine D2 Receptors
J. Neurosci., August 15, 2000; 20(16): 5949 - 5957.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H.-L. Lai, T.-H. Lin, Y.-Y. Kao, W.-J. Lin, M.-J. Hwang, and Y. Chern
The N Terminus Domain of Type VI Adenylyl Cyclase Mediates Its Inhibition by Protein Kinase C
Mol. Pharmacol., September 1, 1999; 56(3): 644 - 650.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
C. Florio, F. Frausin, R. Vertua, and R. M. Gaion
Amplification of the Cyclic AMP Response to Forskolin in Pheochromocytoma PC12 Cells through Adenosine A2A Purinoceptors
J. Pharmacol. Exp. Ther., August 1, 1999; 290(2): 817 - 824.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
W.-J. Tang and J. H. Hurley
Catalytic Mechanism and Regulation of Mammalian Adenylyl Cyclases
Mol. Pharmacol., August 1, 1998; 54(2): 231 - 240.
[Full Text]


Home page
Mol. Pharmacol.Home page
S. J. Mundell, J. L. Benovic, and E. Kelly
A Dominant Negative Mutant of the G Protein-Coupled Receptor Kinase 2 Selectively Attenuates Adenosine A2 Receptor Desensitization
Mol. Pharmacol., June 1, 1997; 51(6): 991 - 998.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
H.-L. Lai, T.-H. Yang, R. O. Messing, Y.-H. Ching, S.-C. Lin, and Y. Chern
Protein Kinase C Inhibits Adenylyl Cyclase Type VI Activity during Desensitization of the A2a-Adenosine Receptor-mediated cAMP Response
J. Biol. Chem., February 21, 1997; 272(8): 4970 - 4977.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N.-K. Huang, Y.-W. Lin, C.-L. Huang, R. O. Messing, and Y. Chern
Activation of Protein Kinase A and Atypical Protein Kinase C by A2A Adenosine Receptors Antagonizes Apoptosis Due to Serum Deprivation in PC12 Cells
J. Biol. Chem., April 20, 2001; 276(17): 13838 - 13846.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1995 by the American Society for Pharmacology and Experimental Therapeutics